Vincerx Pharma, Inc.

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company that went public through a business combination with LifeSci Acquisition Corp (Nasdaq: LSAC), a blank-check company sponsored by LifeSci Capital LLC that completed its IPO in 2019 with a stated focus on life sciences targets. The 8-K filed September 29, 2020 documents a material event in the de-SPAC transaction timeline. Following the completed merger, the combined company traded on Nasdaq under the ticker VINC and advanced a pipeline aimed at hematologic malignancies and broader oncology indications. For comprehensive filing histories, sponsor profiles, and deal-level analytics, create a free account on SpacDesk.